Dr Agarwal’s Health Care IPO

Dr. Agarwal’s Healthcare provides eye care services, including cataract, refractive, and other surgical procedures, along with consultations, diagnostic services, and non-surgical treatments. The company also offers optical products, such as contact lenses, accessories, and eye care-related pharmaceuticals. Its operations are structured into three types of facilities: Primary Facilities, which handle initial diagnosis and clinical investigations; Secondary Facilities, which provide specific services like cataract surgeries; and Tertiary Facilities, which are super-speciality centres. According to the company, these centres are equipped for advanced surgeries, including retinal, corneal, and refractive procedures. Use of proceeds: The IPO is a combination of a fresh issue of shares and an offer-for-sale (OFS). Of the total IPO proceeds of Rs 3,027.26 crore, the selling shareholders get the lion’s share of Rs 2,727.26 crore, while the company gets Rs 300 crore. The selling shareholders are: Dr. Amar Agarwal Dr. Athiya Agarwal Dr. Adil Agarwal Dr. Anosh Agarwal Dr. Ashvin Agarwal Dr. Agarwal's Eye Institute Arvon Investments Pte. Ltd. Claymore Investments (Mauritius) Pte. Ltd. Hyperion Investments Pte. Ltd. Farah Agarwal Urmila Agarwal The funds that will go to the company – Rs 300 crore – will be utilised for: Repayment of outstanding debts General corporate purposes;